Literature DB >> 25203010

Biotech drugs too little, too late for Ebola outbreak.

Stephen Strauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25203010     DOI： 10.1038/nbt0914-849a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Anthrax drug first antibacterial mAb to win approval.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908

2.  Epitopes involved in antibody-mediated protection from Ebola virus.

Authors:  J A Wilson; M Hevey; R Bakken; S Guest; M Bray; A L Schmaljohn; M K Hart
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728
  2 in total
  4 in total

1.  Zika pipeline progresses.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

2.  Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.

Authors:  Alexander Gutfraind; Lauren Ancel Meyers
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

3.  Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis.

Authors:  Feixiong Cheng; James L Murray; Junfei Zhao; Jinsong Sheng; Zhongming Zhao; Donald H Rubin
Journal:  PLoS Comput Biol       Date:  2016-09-15       Impact factor: 4.475

4.  A web-based resource for designing therapeutics against Ebola Virus.

Authors:  Sandeep Kumar Dhanda; Kumardeep Chaudhary; Sudheer Gupta; Samir Kumar Brahmachari; Gajendra P S Raghava
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.